A unique α-1,3 mannosyltransferase of the pathogenic fungus Cryptococcus neoformans

被引:26
|
作者
Doering, TL [1 ]
机构
[1] Cornell Univ Med Coll, Dept Pharmacol, New York, NY USA
关键词
D O I
10.1128/JB.181.17.5482-5488.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The major virulence factor of the pathogenic fungus Cryptococcus neoformans is an extensive polysaccharide capsule which surrounds the cell. Almost 905 of the capsule is composed of a partially acetylated linear alpha-1,3-linked mannan substituted with D-xylose and D-glucuronic acid. A novel mannosyltransferase with specificity appropriate for a role in the synthesis of this glucuronoxylomannan is active in cryptococcal membranes. This membrane-associated activity transfers mannose in vitro from GDP-mannose to an alpha-1,3-dimannoside acceptor, forming a second alpha-1,3 linkage. Product formation by the transferase is dependent on protein, time, temperature, divalent cations, and each substrate. It is not affected by amphomycin or tunicamycin but is inhibited by GDP and mannose-1-phosphate. The described activity is not detectable in the model yeast Saccharomyces cerevisiae, consistent with the absence of a similar polysaccharide structure in that organism. A second mannosyltransferase from C. neoformans membranes adds mannose in alpha-1,2 linkage to the same dimannoside acceptor. The two activities differ in pH optimum and cation preference. While the alpha-1,2 transferase does not have specificity appropriate for a role in glucuronoxylomannan synthesis, it may participate in production of mannoprotein components of the capsule. This study suggests two new targets for antifungal drug discovery.
引用
收藏
页码:5482 / 5488
页数:7
相关论文
共 50 条
  • [1] An α-1,3-mannosyltransferase of Cryptococcus neoformans
    Sommer, U
    Liu, H
    Doering, TL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (48) : 47724 - 47730
  • [2] Characterization of an α-(1,3)-mannosyltransferase from Cryptococcus neoformans
    Sommer, U
    Doering, TL
    GLYCOBIOLOGY, 1999, 9 (10) : 1123 - 1124
  • [3] Initial purification of an -(1,3)-mannosyltransferase from Cryptococcus neoformans
    Sommer, U
    Doering, TL
    GLYCOBIOLOGY, 2000, 10 (10) : 1133 - 1133
  • [4] Capsule synthesis in the pathogenic fungus Cryptococcus neoformans
    Reese, AJ
    Sommer, U
    Liu, H
    Cottrell, TR
    Doering, TL
    GLYCOBIOLOGY, 2003, 13 (11) : 830 - 830
  • [5] RNA interference in the pathogenic fungus Cryptococcus neoformans
    Liu, H
    Cottrell, TR
    Pierini, LM
    Goldman, WE
    Doering, TL
    GENETICS, 2002, 160 (02) : 463 - 470
  • [6] Deciphering the Model Pathogenic Fungus Cryptococcus Neoformans
    Alexander Idnurm
    Yong-Sun Bahn
    Kirsten Nielsen
    Xiaorong Lin
    James A. Fraser
    Joseph Heitman
    Nature Reviews Microbiology, 2005, 3 : 753 - 764
  • [7] Deciphering the model pathogenic fungus Cryptococcus neoformans
    Idnurm, A
    Bahn, YS
    Nielsen, K
    Lin, XR
    Fraser, JA
    Heitman, J
    NATURE REVIEWS MICROBIOLOGY, 2005, 3 (10) : 753 - 764
  • [8] Population genomic analysis of the human pathogenic fungus Cryptococcus neoformans
    Cuomo, C.
    Litvintseva, P.
    MYCOSES, 2014, 57 : 17 - 17
  • [9] Mitochondrial Genome Polymorphisms in the Human Pathogenic Fungus Cryptococcus neoformans
    Wang, Yue
    Xu, Jianping
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [10] Sex-dependent resistance to the pathogenic fungus Cryptococcus neoformans
    van den Berg, Maaike C. W.
    Woerlee, Jessica Z.
    Ma, Hansong
    May, Robin C.
    GENETICS, 2006, 173 (02) : 677 - 683